Alejandro Bustamante Rangel Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Email Alejandro Bustamante Rangel Email Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca
Projects Desarrollo de dianas terapeuticas en la neumonia asociada al ictus a través de la modulación de permeabilidad de la barrera alveolo-capilar IP: Alejandro Bustamante Rangel Collaborators: Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 14640 Reference: MV18/00060 Duration: 01/06/2019 - 20/09/2019 Descubrimiento y validación de biomarcadores de neumonía asociada al ictus IP: Alejandro Bustamante Rangel Collaborators: Noelia Rodríguez Villatoro Funding agency: Instituto de Salud Carlos III Funding: 111320 Reference: PI17/02130 Duration: 01/01/2018 - 01/10/2019 Discovery and clinical usefulness of blood biomarkers in stroke-associated pneumonia. The PROteomics and Transcriptomics in lEUkocyte Subpopulations (PROTEUS) study IP: Olga Maisterra Santos Collaborators: Alejandro Bustamante Rangel, Joan Montaner Villalonga, Anna Penalba Morenilla Funding agency: Fundació La Marató de TV3 Funding: 191375 Reference: 20170630 Duration: 01/01/2018 - 31/12/2021 Incorporació Dr. Joan Montaner a la RETICS en Malalties vasculars cerebrals (ICTUS) IP: - Collaborators: Anna Rosell Novel, Mercedes Arrue Gonzalo, Alejandro Bustamante Rangel, Marcel Lamana Vallverdu, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez, Guillem Colell Dinares, Gema Esquiva Sobrino, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel Funding agency: Instituto de Salud Carlos III Funding: 240669 Reference: RD16/0019/0021 Duration: 01/01/2017 - 31/12/2021 Pagination Current page 1 Page 2 Page 3 Page 4 Next page › Last page »
